4
Changes in Ownership
Bausch Health Companies Inc. Filed Acc 0000899243-22-008826
CEO, Pharma Business gave up 13,376 shares (to pay taxes)
- CEO, Pharma Business acquired 24,292 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| APPIO THOMAS CEO, Pharma Business | 2022-02-27 | Option exercise | +24,292 | 341,517 | D: show line 1 in the form | ||
| APPIO THOMAS CEO, Pharma Business | 2022-02-27 | Shares withheld for taxes | −8,782 | $24.35 | $213,842 | 332,735 | D: show line 2 in the form |
| APPIO THOMAS CEO, Pharma Business | 2022-02-26 | Shares withheld for taxes | −2,192 | $24.35 | $53,375 | 330,543 | D: show line 3 in the form |
| APPIO THOMAS CEO, Pharma Business | 2022-02-27 | Shares withheld for taxes | −2,402 | $24.35 | $58,489 | 328,141 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| APPIO THOMAS CEO, Pharma Business | 2022-02-27 | Grant or award · Restricted Share Units | +24,292 | 0 | D: show line 5 in the form | ||
| APPIO THOMAS CEO, Pharma Business | 2022-02-27 | Option exercise · Restricted Share Units | −24,292 | $24.35 | $591,510 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…